195 related articles for article (PubMed ID: 30409717)
21. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
[TBL] [Abstract][Full Text] [Related]
22. Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study.
Partin MR; Lillie SE; White KM; Wilt TJ; Chrouser KL; Taylor BC; Burgess DJ
Health Expect; 2017 Aug; 20(4):779-787. PubMed ID: 27807905
[TBL] [Abstract][Full Text] [Related]
23. Low-Value Prostate Cancer Screening Among Older Men Within the Veterans Health Administration.
Radomski TR; Huang Y; Park SY; Sileanu FE; Thorpe CT; Thorpe JM; Fine MJ; Gellad WF
J Am Geriatr Soc; 2019 Sep; 67(9):1922-1927. PubMed ID: 31276198
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer detection in veterans with a history of Agent Orange exposure.
Zafar MB; Terris MK
J Urol; 2001 Jul; 166(1):100-3. PubMed ID: 11435832
[TBL] [Abstract][Full Text] [Related]
25. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
[TBL] [Abstract][Full Text] [Related]
26. Long-term depression incidence and associated mortality among African American and White prostate cancer survivors.
Parikh RB; Gallo JJ; Wong YN; Robinson KW; Cashy JP; Narayan V; Jayadevappa R; Chhatre S
Cancer; 2021 Sep; 127(18):3476-3485. PubMed ID: 34061986
[TBL] [Abstract][Full Text] [Related]
27. Knowledge of prostate cancer among African American men: A systematic review.
Coughlin SS; Vernon M; Klaassen Z; Tingen MS; Cortes JE
Prostate; 2021 Feb; 81(3):202-213. PubMed ID: 33368465
[TBL] [Abstract][Full Text] [Related]
28. Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation.
Saltzman AF; Luo S; Scherrer JF; Carson KD; Grubb RL; Hudson MA
Urol Oncol; 2015 Jul; 33(7):330.e9-17. PubMed ID: 25937424
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
[TBL] [Abstract][Full Text] [Related]
30. Screening for prostate cancer in African Americans.
Moul JW
Curr Urol Rep; 2000 May; 1(1):57-64. PubMed ID: 12084342
[TBL] [Abstract][Full Text] [Related]
31. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
[TBL] [Abstract][Full Text] [Related]
32. Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.
Mandal DM; Sartor O; Halton SL; Mercante DE; Bailey-Wilson JE; Rayford W
Prostate Cancer Prostatic Dis; 2008; 11(3):274-9. PubMed ID: 18268528
[TBL] [Abstract][Full Text] [Related]
33. Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening Patterns.
Hansen M; Hamieh NM; Markt SC; Vaselkiv JB; Pernar CH; Gonzalez-Feliciano AG; Peisch S; Chowdhury-Paulino IM; Rencsok EM; Rebbeck TR; Platz EA; Giovannucci EL; Wilson KM; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):982-990. PubMed ID: 35247879
[TBL] [Abstract][Full Text] [Related]
34. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
[TBL] [Abstract][Full Text] [Related]
35. Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening.
Vertosick EA; Poon BY; Vickers AJ
J Urol; 2014 Sep; 192(3):724-8. PubMed ID: 24641912
[TBL] [Abstract][Full Text] [Related]
36. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
37. The Association of Veterans' PSA Screening Rates With Changes in USPSTF Recommendations.
Becker DJ; Rude T; Walter D; Wang C; Loeb S; Li H; Ciprut S; Kelly M; Zeliadt SB; Fagerlin A; Lepor H; Sherman S; Ravenell JE; Makarov DV
J Natl Cancer Inst; 2021 May; 113(5):626-631. PubMed ID: 32797212
[TBL] [Abstract][Full Text] [Related]
38. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Alexa, Google Assistant, and Siri for Supporting Informed Prostate Cancer Screening Decisions for African-American Men.
Owens OL; Leonard M; Singh A
J Cancer Educ; 2023 Oct; 38(5):1752-1759. PubMed ID: 37382796
[TBL] [Abstract][Full Text] [Related]
40. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
